We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PALIPERIDONE ADVZ (Amdipharm Mercury Australia Pty Ltd)
Product name
PALIPERIDONE ADVZ
Date registered
Evaluation commenced
Decision date
Approval time
203 (255 working days)
Active ingredients
paliperidone palmitate
Registration type
New generic medicine
Indication
[TRADENAME] is indicated or the acute and maintenance treatment of schizophrenia in adults.